Market Research Report
MediPoint: Aortic Stent Grafts - Global Analysis and Market Forecasts
|Published by||GlobalData||Product code||316749|
|Published||Content info||260 Pages
|MediPoint: Aortic Stent Grafts - Global Analysis and Market Forecasts|
|Published: October 15, 2014||Content info: 260 Pages||
This publication has been discontinued on January 18, 2018.
Aortic stent grafts are most commonly used to reinforce a weak spot in an artery, which is known as an aneurysm. The stent grafts are designed to seal tightly with the patient's native artery above and below the aneurysm, and are used to treat abdominal aortic aneurysms as well as thoracic aortic aneurysms. Aortic aneurysms, as opposed to aneurysms found elsewhere in the body, are potentially very serious, as a burst aorta results in massive internal bleeding that can be fatal unless treated rapidly by an experienced emergency medical team. Since their introduction in patients in 1991, aortic stent graft devices have gained wide acceptance and availability, with their adoption fueled in great part by advances in stent-graft design and by a variety of devices for various anatomic features. Over time, these devices have gained traction for use in patients with ruptured aneurysms because they are minimally invasive and have shorter recovery times.
This report focuses on the aortic stent graft implant market for abdominal and thoracic aneurysms. The abdominal aortic market comprises about 80-90% of the market, with the niche market being the thoracic one. The thoracic aneurysm repair market is still a young market where there is a strong pipeline of products from both the large manufacturers and small emerging players. For most manufacturers, following the successful launch of an AAA product, the thoracic stent graft segment presents the opportunity with the most unmet needs for pursuit.
The 10MM are covered and forecast in this report, which provides the unmet needs, future adoption, and Compound Annual Growth Rates (CAGRs) in both the abdominal stent graft and thoracic stent graft markets. GlobalData's analysis demonstrates this market to be a young and growing market, subject to rapid technological development and with much room for product adoption. The global aortic stent grafts market is determined for the 10 countries with insight into the competitive landscape, the marketed and pipeline products, the current and emerging players and market analysis. The report identifies the unmet needs in the market while providing an understanding of physicians' perceptions and decision-making processes in using and evaluating the adoption of the stent graft.